Abstract
Sporadic Alzheimer's disease (AD) and autosomal dominant Alzheimer's disease (ADAD) share pathological features, but differing mechanisms, leading to disease. In this issue of Neuron, Almeida, Eger, et al.1 uncovered molecular processes that may distinguish sporadic AD from ADAD and how the APOE-Christchurch variant may be protective.
Original language | English |
---|---|
Pages (from-to) | 1723-1724 |
Number of pages | 2 |
Journal | Neuron |
Volume | 112 |
Issue number | 11 |
DOIs |
|
State | Published - Jun 5 2024 |